USPTO serial 79433300
XGENERA
Reviewed by CopyMark Law Group
Status 641Office Action
- Filing date
- Status date
- Registration date
- —
- Examiner
- HARMON, RAYMOND E
- Law office
- TMEG LAW OFFICE 103
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Need help with XGENERA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, cancer and pre-cancerous conditions, cardiovascular and cerebrovascular diseases, neurological and neurodegenerative diseases, infectious diseases, inflammatory and autoimmune diseases, metabolic and endocrine diseases, respiratory disease, renal and urological diseases, reproductive related conditions; chemical preparations for testing blood for medical purposes; diagnostic preparations for medical purposes; diagnostic preparations for medical purposes used by medical laboratories; reagents for use in medical testing; diagnostic testing materials for medical use; medical diagnostic test strips for use in the field of oncology, cardiology, neurology, infectious disease, immunology, endocrinology, respiratory medicine, nephrology urology and obstetrics; medical diagnostic reagents; medical testing kits comprised of medical diagnostic reagents and assays for testing body fluids; diagnostic kits comprising diagnostic agents, preparations and substances for medical purposes; chemical preparations for the testing of blood and urine for medical purposes | ACTIVE | — |
| 010 | Medical testing instruments and apparatus, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing; apparatus and instruments for use in medical analysis, namely, for detecting and measuring analytes in biofluids; testing probes and testing apparatus for medical diagnostic purposes, namely, medical diagnostic apparatus for testing cancer cells, human blood, urine, tissue, and biofluids; apparatus for DNA and RNA testing for medical purposes; diagnostic instruments for medical use, namely, medical diagnostic apparatus for testing biomarkers; medical test kits for identifying oncological, viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, hepatological, ophthalmic, respiratory, gastrointestinal, hormonal, dermatological, immune system related infection and disease; medical test kits for diagnostic cancer and pre-cancerous conditions, cardiovascular and cerebrovascular diseases, neurological and neurodegenerative diseases, infectious diseases, inflammatory and autoimmune diseases, metabolic and endocrine diseases, respiratory disease, renal and urological diseases, reproductive related conditions detection purposes; blood and urine testing and analysis apparatus and instruments | ACTIVE | — |
| 044 | Medical testing services; medical analysis services for the diagnosis and treatment of persons; medical testing services relating to the diagnosis and treatment of disease; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical testing and medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical screening; medical testing services for blood and urine testing; medical analysis services for diagnostic and treatment purposes provided by medical laboratories, namely, analysis of human blood, urine, tissue and cells for medical treatment and diagnostics; medical analysis services for the diagnosis of cancer; medical analysis services for diagnostic and treatment purposes provided by medical laboratories, namely, RNA or DNA analysis services for cancer diagnosis and prognosis; medical laboratory services for the analysis of samples taken from patients relating to the treatment of persons | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 31, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 31, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 31, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 8, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 8, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 8, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 29, 2026 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jan 15, 2026 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jan 15, 2026 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Dec 6, 2025 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Dec 5, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 28, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 29, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 29, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 25, 2025 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |